On Invalid Date, Merck & Co (NYSE: MRK) reported Q3 2022 earnings per share (EPS) of $1.28, up 29.28% year over year. Total Merck & Co earnings for the quarter were $3.25 billion. In the same quarter last year, Merck & Co's earnings per share (EPS) was $1.81.
As of Q1 2023, Merck & Co's earnings has grown 111.58% year over year. This is 72.07 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 39.51%. Merck & Co's earnings in the past year totalled $15.26 billion.
What is MRK's earnings date?
Merck & Co's earnings date is Invalid Date. Add MRK to your watchlist to be reminded of MRK's next earnings announcement.
What was MRK's revenue last quarter?
On Invalid Date, Merck & Co (NYSE: MRK) reported Q3 2022 revenue of $14.96 billion up 13.72% year over year. In the same quarter last year, Merck & Co's revenue was $13.15 billion.
What was MRK's revenue growth in the past year?
As of Q1 2023, Merck & Co's revenue has grown 27.84% year over year. This is 15.48 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 12.36%. Merck & Co's revenue in the past year totalled $58.97 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.